Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02204709 · ClinicalTrials.gov registry record · NA
Disease Risk Reduction and Omega-3 Rich Rainbow Trout (Fish for Health)
A NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT02204709: Clinical Trial NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
NCT02204709 is a NA study that was terminated before completion, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02204709, a NA study, was terminated before completion, sponsored by USDA Grand Forks Human Nutrition Research Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how eating fish raised to have different levels of omega-3 fatty acids will reduce cardiovascular risk markers in people with elevated cardiovascular risk.
Interventions
- OTHER 2N Trout
- OTHER 3N Trout
- OTHER Tilapia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2015-06 |
| Est. Completion | 2020-03-25 |
| Phase | NA |
Why NCT02204709 stopped before completion
NCT02204709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which 2N Trout is the first listed.
NCT02204709 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02204709 about?
NCT02204709 is a clinical study titled "Disease Risk Reduction and Omega-3 Rich Rainbow Trout (Fish for Health)". The purpose of this study is to determine how eating fish raised to have different levels of omega-3 fatty acids will reduce cardiovascular risk markers in people with elevated cardiovascular risk.
What is the current status of trial NCT02204709?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2015-06. Estimated completion is 2020-03-25.
What interventions are being tested in trial NCT02204709?
The interventions under investigation include: 2N Trout (OTHER), 3N Trout (OTHER), Tilapia (OTHER).
Who is sponsoring clinical trial NCT02204709?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02204709's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia